Mitsuyama Yasuhito, Sata Hiroshi, Yasumi Masato, Imakita Masami, Karasuno Takahiro
Dept. of Hematology, Rinku General Medical Center.
Gan To Kagaku Ryoho. 2020 Oct;47(10):1513-1515.
Most primary gastric mucosa-associated lymphoid tissue(MALT)lymphomas are associated with a chronic Helicobacter pylori(H. pylori)infection. The eradication of H. pylori is the first-line treatment for H. pylori-positive cases with early-stage disease. In addition, successful treatment of H. pylori-negative early stage MALT lymphomas by eradication has been reported in several small cases series. However, the association of primary gastrointestinal MALT lymphomas with H. pylori in areas other than the stomach is not clear, and the efficacy of eradication therapy for these patients has not been established. We performed H. pylori eradication therapy for H. pylori-negative cecum MALT lymphoma. Three months later, a histopathological examination showed no evidence of MALT lymphoma, and the patient was classified as being in remission. So far, the patient has been in remission for 1 year and 6 months. Our case is the first report of successfully treating H. pylori- negative cecum MALT lymphoma with eradication therapy.
大多数原发性胃黏膜相关淋巴组织(MALT)淋巴瘤与慢性幽门螺杆菌(H. pylori)感染有关。根除幽门螺杆菌是早期幽门螺杆菌阳性病例的一线治疗方法。此外,在几个小病例系列中报告了通过根除成功治疗幽门螺杆菌阴性的早期MALT淋巴瘤。然而,原发性胃肠道MALT淋巴瘤在胃以外区域与幽门螺杆菌的关联尚不清楚,并且这些患者根除治疗的疗效尚未确立。我们对幽门螺杆菌阴性的盲肠MALT淋巴瘤进行了幽门螺杆菌根除治疗。三个月后,组织病理学检查显示没有MALT淋巴瘤的证据,该患者被分类为缓解期。到目前为止,该患者已缓解1年零6个月。我们的病例是首例关于用根除疗法成功治疗幽门螺杆菌阴性盲肠MALT淋巴瘤的报告。